Biological Parameters for Evaluating the Toxic Potency of Petroleum Ether Extract of Wattakaka volubilis in Wistar Female Rats

  • Gopal, Velmani (Pharmacognosy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadavpur University) ;
  • Agrawal, Nitin (Pharmacognosy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadavpur University) ;
  • Mandal, Subhash C. (Pharmacognosy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceutical Technology, Jadavpur University)
  • Received : 2014.08.18
  • Accepted : 2014.08.27
  • Published : 2014.09.30


Objectives: The present study investigated the toxic properties of petroleum ether extract of Wattakaka (W.) volubilis in Wistar female rats. Methods: An in vitro brine shrimp lethality bioassay was studied in A. Salina nauplii, and the lethality concentrations were assessed for petroleum ether extract of W. volubilis. A water soluble portion of the test extract was used in different concentrations from $100-1000{\mu}g/mL$ of 1 mg/mL stock solution. A 24-hours incubation with a 1-mL aliquot in 50 mL of aerated sea water was considered to calculate the percentage rate of dead nauplii with test extract administration against a potassium-dichromate positive control. The acute and the sub-acute toxicities of petroleum ether extract of W. volubilis were evaluated orally by using gavage in female Wistar rats. Food and water intake, body weight, general behavioral changes and mortality of animals were noted. Toxicity or death was evaluated following the administration of petroleum ether extract for 28 consecutive days in the female rats. Serum biochemical parameters, such as alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, total cholesterol, triglyceride, total protein, glucose, urea, creatinine, sodium, potassium and ${\alpha}$-amylase levels, were measured in the toxicity evaluations. Pathological changes in isolated organs, such as the liver, kidneys, and pancreas, were also examined using hematoxylin and eosin dye fixation after the end of the test extract's administration. Results: The results of the brine-shrimp assay indicate that the evaluated concentrations of petroleum ether extract of W. volubilis were found to be non-toxic. In the acute and the sub-acute toxicity evaluations, no significant differences were observed between the control animals and the animals treated with extract of W. volubilis. No abnormal histological changes were observed in any of the animal groups treated with petroleum ether extract of W. volubilis. Conclusion: These results suggest that petroleum ether extract of W. volubilis has a non-toxic effect in Wistar female rats.


  1. Da Costa JM, Campos AR, Brito SA, Pereira CKB, Souza EO, Rodrigues FFG. Biological screening of araripe basin medicinal plants using artemia salina leach and pathogenic bacteria. Pharmacogn Mag. 2010;6(24):331-4.
  2. Panda N, Banerjee S, Mandal NB, Sahu NP. Pregnane glycosides. Nat Prod Comm. 2006;3:665-9.
  3. Kirtikar KR, Basu BD. India medicinal plants, Bishen Singh Mahendrapal Singh, Dehradun. 2003;3:1635.
  4. Ayyanar M, Sankara sivaraman K, Ignacimuthu S. Traditional herbal medicines used for the treatment of diabetes among two major tribal groups in south Tamil Nadu, India. Ethno Botanical Leaflet. 2008;12:276-80.
  5. Yoshimura S, Narita H, Hayashi K, Mitsuhashi H. Studies on the constituents of asclepiadaceae plants. LVI. isolation of new antitumor-active glycosides from dregea volubilis (L.) BENTH. Chem Pharm Bull.1983;31(11):3971-83.
  6. Biswas M, Bera S, Biswakanth K, Karan TK, Bhattacharya S, Ghosh AK, et al. Antitumor effect of dregea volubilis fruit in ehrlich ascites carcinoma bearing mice. Global J Pharmacol. 2010;4:102-6.
  7. Biswas M, Biswas K, Ghosh AK, Haldar PK. A pentacyclic triterpenoid possessing analgesic activity from the fruits of dregea volubilis. Pharmacogn Mag. 2009;5:90-2.
  8. Arun kumar R, Ali Ahmed AB, Venkateshvaran, Mani P, John bastin TMM. Anti-hyperlipidemic and hypoglycemic activity of wattakaka volubilis methanol extract in alloxan- induced diabetic rats. J Pharma Res. 2010;3:1913-5.
  9. Velmani G, Vivekananda M, Mandal SC. A critical biochemical assessment on the antihyperglycemic activity of aqueous fraction of wattakaka volubilis supported by antioxidant defense. Orient Pharm Exp Med, 2014;14(1):15-24.
  10. Hossain E, Sarkar D, Maiti A, Chatterjee M, Mandal SC, Gupta JK. Anti-inflammatory effect of a methanolic extract of leaves of dregea volubilis. J Ethnopharmacol. 2010;132(2):525-8.
  11. Nandi D, Elizabeth Besra S, Vedasiromoni JR, Giri SV, Prince R, Parasuraman J. Anti-leukemic activityof wattakaka volubilis leaf extract against human myeloid leukemia cell lines. J Ethnopharmacol. 2012;144(2):466-73.
  12. Hossain E, Chandra G, Nandy AP, Mandal SC, Gupta JK. Anthelmintic effect of a methanol extract of leaves of dregea volubilis on paramphistomum explanatum. Parasitol Res. 2012;110(2):809-14.
  13. Meyer B, Ferrigni N, Putnam J, Jacobsen L, Nichols D, McLaughlin J. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Medica. 1982;45(5):31-4.
  14. Solis PN, Wright CW, Anderson MM, Gupta MP, Phillipson JD. A microwell cytotoxicity assay using artemia salina. Planta Medica. 1993;59(3): 250-2.
  15. Cepleanu F, Hamburger M, Sordat B, Msonthi J, Gupta M, Saadou M, et al. Screening of tropical medicinal plants for molluscicidal, larvicidal, fungicidal and cytotoxic activities and brine shrimp toxicity. Pharm Biol. 1994;32(3): 294-307.
  16. Suresh Kumar RB, Puratchikodi A, Angelene Prasanna, Narayan Dolai, Piyali Majumder, Mazumder UK, et al. 2011. Pre clinical studies of streblus asper lour in terms of behavioural safety and toxicity. Orient Pharm Exp Med. 2011;11(4):243-9.
  17. OECD., 2002. OECD guide lines for the testing of chemicals / section 4: health effects test no 423: Acute oral toxicity-Acute toxic class method. OECD Paris.
  18. OECD., 1995. Guide-line for testing of chemicals. Guideline 407: Repeated Dose 28-day Oral Toxicity Study in Rodents. OECD Paris.
  19. Malek, D, Malley L, Slone T, Elliott G, Kennedy G, Mellert W, et al. Repeated dose toxicity study (28 days) in rats and mice with N methylpyrrolidone (NMP). Drug Chem Toxicol. 1997;20(1-2):63-77.
  20. Gupta M, Monge A, Karikas G, Lopez de Cerain A, Solis P, De Leon E, et al. Screening of panamanian medicinal plants for brine shrimp toxicity, crown gall tumor inhibition, cytotoxicity and DNA intercalation. Pharm Biol. 1996;34(1):19-27.
  21. Deciga-Campos M, Rivero-Cruz I, Arriaga-Alba M, Castaneda-Corral G, Angeles-Lopez GE, Navarrete A, et al. Acute toxicity and mutagenic activity of mexican plants used in traditional medicine. J Ethnopharmacol. 2007;110(2): 334-42.
  22. Arts JH, Muijser H, Appel MJ, Frieke Kuper C, Bessems JG, Woutersen RA. Subacute (28-day) toxicity of furfural in fischer 344 rats: a comparison of the oral and inhalation route. Food Chem Toxicol. 2004;42(9):1389-99.
  23. Bautista ARPL, Moreira ELT, Batista MS, Miranda MS, Gomes ICS. Subacute toxicity assessment of annatto in rat. Food Chem Toxicol. 2004;42(4):625-9.
  24. Wannang NN, Jimam NS, Omale S, Maxwell LPD, Steven SG, Aguiyi JC. Effect of cucumis metuliferus (cucurbitaceae) fruits on enzymes and haematological parameters in albino rats. Afr J Biotechnol. 2007;6(22):2515-8.
  25. Mauer SM, Steffes MW, Brown DM. The kidney in diabetes. Am J Med. 1981;70(3):603-12.
  26. Almadal TP, Vilstrup H. Strict insulin treatment normalizes the organic nitrogen contents and the capacity of urea-N synthesis in experimental diabetes in rats. Diabetologica.1988;31(2):114-8.
  27. Kerl ME. Diabetic ketoacidosis: pathophysiology and clinical laboratory presentation. Comp Cont Educ Pract Vet. 2001;23(3):220-9.
  28. Tarling CA, Woods K, Zhang R, Brastianos HC, Brayer GD, Andersen RJ, et al. The search for novel human pancreatic alpha-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts. Chem Bio Chem. 2008;9(3): 433-8.